Artificial intelligence predicts ovarian cancer patients’ survival rate
Researchers from Imperial College London and the University of Melbourne have created artificial...
Trending:
-
![FDA clears Tandem Diabetes’ t:Slim X2 insulin pump]()
FDA clears Tandem Diabetes’ t:Slim X2 insulin pump
-
![J&J to acquire surgical robotics firm Auris Health for $3.4bn]()
J&J to acquire surgical robotics firm Auris Health for $3.4bn
-
![Future of the NHS 2019]()
NHS Long Term Plan: digging into the details with tech experts DXC
-
![Health data access]()
Democratising data: the key to better healthcare?
-
![cataract-surgery-SimVis]()
Simulator shows patients how cataract surgery can improve their vision
-
![Pistoia Alliance to use blockchain for data sharing]()
Pistoia Alliance to use blockchain for data sharing
Most Read
- Artificial intelligence predicts ovarian cancer patients’ survival rate
- FDA clears Tandem Diabetes’ t:Slim X2 insulin pump
- IBM Watson, Broad Institute predict heart disease with genomics and AI
- J&J to acquire surgical robotics firm Auris Health for $3.4bn
- NHS Long Term Plan: digging into the details with tech experts DXC
Company A-Z
Latest Content
Artificial intelligence predicts ovarian cancer patients’ survival rate
Researchers from Imperial College London and the University of Melbourne have created artificial intelligence (AI) software that can predict the prognosis of ovarian cancer patients more accurately than current methods and determine which treatments would be most effective for each individual.
FDA clears Tandem Diabetes’ t:Slim X2 insulin pump
The US Food and Drug Administration (FDA) has granted marketing clearance for the Tandem Diabetes Care’s t:Slim X2 insulin pump, which can deliver insulin under the skin in children and adults with diabetes.
IBM Watson, Broad Institute predict heart disease with genomics and AI
IBM Watson Health has expanded its partnership with the Broad Institute of MIT and Harvard to work on a project that will leverage genomics, clinical data and artificial intelligence (AI) to predict serious cardiovascular diseases.
J&J to acquire surgical robotics firm Auris Health for $3.4bn
Johnson & Johnson (J&J), through its subsidiary Ethicon, has signed a definitive agreement to buy surgical robotics maker Auris Health for a cash consideration of around $3.4bn
NHS Long Term Plan: digging into the details with tech experts DXC
The NHS Long Term Plan commits the UK’s health service, alongside other elements, to an enhanced focus on integration of technology and data into its day-to-day operations. Colin Henderson and Dr David Lee of IT services company DXC discuss the most exciting aspects of the plan, how it will benefit the NHS and enthusiasm about its deliverability in the face of challenges.
MDW, Longenesis and Bitfury to bring blockchain to medical imaging
Radiology solutions provider Medical Diagnostic Web (MDW) has partnered with Longenesis and Bitfury Group to implement a healthcare blockchain technology across its marketplace.
Francisco Partners buys device connectivity firm Qualcomm Life
Private equity firm Francisco Partners has acquired medical device connectivity solutions provider Qualcomm Life for an undisclosed amount.
Democratising data: the key to better healthcare?
Giving patients access to their medical data offers an advantageous realignment of the doctor-patient dynamic. But with the benefits come complications, and progress towards digital health goals vary wildly. What are the obstacles still lying in the way of democratising healthcare data, and how can these goals be best pursued in the interest of patient care and sustainable health systems?
Hitachi and partners develop technology to diagnose concurrent ASD
Hitachi has partnered with universities in Japan to develop fundamental technology for the early differential diagnosis of concurrent autism spectrum disorder (ASD) in attention-deficit hyperactivity disorder (ADHD) patients.
Simulator shows patients how cataract surgery can improve their vision
Scientists from the Spanish National Research Council (CSIC) have developed a wearable visual simulator, called SimVis, which enables patients to experience how their vision will improve after having cataract surgery.
Latest News
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.
Go Top
